| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |